Calcimedica, Inc.
Clinical trials sponsored by Calcimedica, Inc., explained in plain language.
CalciMedica, Inc.
CALC
NASDAQ
Clinical-stage biopharmaceutical company developing calcium release-activated calcium (CRAC) channel inhibitors.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.